Metsera Inc(MTSR-Q)
NASDAQ

Today's Change
Delayed Last Update
Day Low70.13
Day High70.78
Open:70.74
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Tipranks
Metsera’s MET097 Phase 2b Obesity Trial Reaches Completion: What Investors Should Watch Next
Tipranks
Pfizer’s MET097 Obesity Trial Reaches Key Milestone: What Investors Should Watch Next
Motley Fool
Can AI Drive Peloton's Comeback?
Motley Fool
Down 55%, Should You Buy the Dip on Pfizer?
Motley Fool
Is Pfizer Stock a Buy After This $10 Billion Acquisition?
Tipranks
Metsera, Inc. Completes Merger and Restructures Leadership
Motley Fool
Why Is Everyone Talking About Novo Nordisk Stock?
Business Wire
Pfizer Completes Acquisition of Metsera
Motley Fool
Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?
Motley Fool
Why Metsera's Share Price Is Plummeting This Week
Motley Fool
Where Will Pfizer Be in 3 Years?
Tipranks
Metsera Amends Merger Agreement with Pfizer
Motley Fool
Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
Tipranks
Metsera Considers Novo Nordisk’s Superior Acquisition Proposal
SYNDTGAM
Wegovy maker Novo Nordisk cuts guidance again but Medicare pricing deal uplifts investors
A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. REUTERS/Tom Little
Motley Fool
Here's Why Shares in Viking Therapeutics Shot Higher in October
Tipranks
Metsera, Inc. Responds to Pfizer’s Litigation Claims
Motley Fool
Did Novo Nordisk Just Say "Checkmate" to Pfizer?
Motley Fool
Meet the 7% Yield Dividend Stock That Could Soar in 2026

Profile

Metsera Inc. is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight and related conditions. Metsera Inc. is based in NEW YORK.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.